Literature DB >> 21078663

NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Melissa A Farrow1, Eun-Young Kim, Steven M Wolinsky, Ann M Sheehy.   

Abstract

The human cytidine deaminase APOBEC3G (A3G) is an innate restriction factor that inhibits human immunodeficiency virus, type 1 (HIV-1) replication. Regulation of A3G gene expression plays an important role in this suppression. Currently, an understanding of the mechanism of this gene regulation is largely unknown. Here, we have identified and characterized a TATA-less core promoter with an NFAT/IRF-4 composite binding site that confers cell type-specific transcriptional regulation. We found that A3G expression is critically dependent on NFATc1/NFATc2 and IRF-4. When either NFATc1 or NFATc2 and IRF-4 were co-expressed, A3G promoter activity was observed in cells that normally lack A3G expression and expression was not detected in the presence of the individual factors. This induced A3G expression allowed normally permissive CEMss cells to adopt a nonpermissive state, able to resist an HIV-1Δvif challenge. This represents the first reporting of manipulating the restrictive state of a cell type via gene regulation. Identification of NFAT and IRF family members as critical regulators of A3G expression offers important insight into the transcriptional control mechanisms that regulate innate immune responses and identifies specific targets for therapeutic intervention aimed at effectively boosting our natural immunity, in the form of a host defensive factor, against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078663      PMCID: PMC3024752          DOI: 10.1074/jbc.M110.154377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Interferon regulatory factors: the next generation.

Authors:  Y Mamane; C Heylbroeck; P Génin; M Algarté; M J Servant; C LePage; C DeLuca; H Kwon; R Lin; J Hiscott
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

2.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

3.  E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).

Authors:  Nienke van der Stoep; Edwin Quinten; Marisa Marcondes Rezende; Peter J van den Elsen
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

4.  E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.

Authors:  Adam S Lazorchak; Mark S Schlissel; Yuan Zhuang
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 5.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.

Authors:  Xia Jin; Andy Brooks; Huiyuan Chen; Ryan Bennett; Richard Reichman; Harold Smith
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  APOBEC3G genetic variants and their influence on the progression to AIDS.

Authors:  Ping An; Gabriela Bleiber; Priya Duggal; George Nelson; Margaret May; Bastien Mangeat; Irene Alobwede; Didier Trono; David Vlahov; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Stephen J O'Brien; Amalio Telenti; Cheryl A Winkler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.

Authors:  Kim Stopak; Carlos de Noronha; Wes Yonemoto; Warner C Greene
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

9.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

10.  Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.

Authors:  Kristine M Rose; Mariana Marin; Susan L Kozak; David Kabat
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

View more
  19 in total

1.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

4.  Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.

Authors:  Xue Wang; Jiying Tan; Jiangqin Zhao; Viswannath Ragupathy; Mohan Haleyurgirisetty; Indira Hewlett
Journal:  Mol Cell Biochem       Date:  2014-04-22       Impact factor: 3.396

5.  Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.

Authors:  Nicole Lenz; Tobias Schindler; Benjamin M Kagina; Jitao David Zhang; Tedson Lukindo; Maxmillian Mpina; Peter Bang; Ingrid Kromann; Søren T Hoff; Peter Andersen; Klaus Reither; Gavin J Churchyard; Ulrich Certa; Claudia A Daubenberger
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

6.  Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein.

Authors:  Zachary L Demorest; Ming Li; Reuben S Harris
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

7.  B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.

Authors:  Zhiquan Wang; Huihuang Yan; Justin C Boysen; Charla R Secreto; Renee C Tschumper; Dania Ali; Qianqian Guo; Jian Zhong; Jiaqi Zhou; Haiyun Gan; Chuanhe Yu; Diane F Jelinek; Susan L Slager; Sameer A Parikh; Esteban Braggio; Neil E Kay
Journal:  Blood Cancer J       Date:  2022-07-01       Impact factor: 9.812

8.  Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy.

Authors:  Iraj Hosseini; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2012-02-09       Impact factor: 4.475

9.  APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.

Authors:  Ann M Sheehy; Julie Erthal
Journal:  Mol Biol Int       Date:  2012-06-06

10.  RNA-Seq analysis of high NaCl-induced gene expression.

Authors:  Yuichiro Izumi; Wenjing Yang; Jun Zhu; Maurice B Burg; Joan D Ferraris
Journal:  Physiol Genomics       Date:  2015-07-28       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.